Article
Toward a pathophysiology inspired treatment of VEXAS syndrome.
Seminars in hematology - 1 Oct 2021
Heiblig Maël, Patel Bhavisha A, Groarke Emma M, Bourbon Estelle, Sujobert Pierre
Abstract excerpt
VEXAS syndrome has an unmet need for therapeutic interventions. Even if few data exist regarding the treatment of this newly described syndrome, different options can be proposed given the unique pathophysiological consequences of the clonal dominance of UBA1 mutated hematopoietic stem cells. To date, allogeneic transplantation is the only curative option, but many questions remain regarding the selection of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
